Diabetes and cardiovascular risk evaluation and management in primary care:: progress and unresolved issues -: Rationale for a nationwide primary care project in Germany

被引:8
作者
Böhler, S
Glaesmer, H
Pittrow, D
Lehnert, H
Stalla, GK
Zeiher, AM
März, W
Silber, S
Wehling, M
Ruf, G
Reinecke, A
机构
[1] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-8027 Dresden, Germany
[2] Pfizer GmbH, Int Med Res, Freiburg, Germany
[3] Tech Univ Dresden, Inst Clin Pharmacol, Res Fed Publ Hlth Sachsen, D-8027 Dresden, Germany
[4] Otto Von Guericke Univ, Dept Endocrinol & Metab Disorders, Magdeburg, Germany
[5] Max Planck Inst Psychiat, Dept Endocrinol, D-80804 Munich, Germany
[6] Goethe Univ Frankfurt, Dept Cardiol Nephrol, D-6000 Frankfurt, Germany
[7] Univ Med Graz, Clin Inst Med & Chem, Diagnost Lab, Graz, Austria
[8] Heidelberg Univ, Inst Clin Pharmacol Mannheim, D-68167 Mannheim, Germany
[9] Pfizer GmbH, Clin Res, Karlsruhe, Germany
[10] Max Planck Inst Psychiat, Dept Clin Psychol & Epidemiol, D-80804 Munich, Germany
关键词
coronary heart disease; type 2 diabetes mellitus; primary care; risk markers; epidemiology;
D O I
10.1055/s-2004-817927
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review highlights established and more recently recognized risk factors for coronary heart disease (CHD) relevant for patients seen in primary care, emphasizing the key role of diabetes mellitus type 2. Recent trends in risk factor research as well as current methods of risk stratification, and new systemic markers are discussed. Beyond the need for more forceful public health strategies to improve early recognition and intervention, the necessity of an integrated comprehensive investigation of the overall characteristics of cardiovascular disease, especially in primary care patients as a prerequisite for future concerted actions is pointed out. Based on this, a large-scale epidemiological investigation focusing on CHD and diabetes in the primary care sector is suggested.
引用
收藏
页码:157 / 170
页数:14
相关论文
共 138 条
[11]   Association between postprandial hyperinsulinemia and coronary artery disease among non-diabetic women: a case control study [J].
Baltali, M ;
Korkmaz, ME ;
Kiziltan, HT ;
Muderris, IH ;
Ozin, B ;
Anarat, R .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2003, 88 (2-3) :215-221
[12]   The search for new risk factors for coronary heart disease: occupational therapy for epidemiologists? [J].
Beaglehole, R ;
Magnus, P .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (06) :1117-1122
[13]   Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management [J].
Beckman, JA ;
Creager, MA ;
Libby, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19) :2570-2581
[14]   Task force #1 - Magnitude of the prevention problem: Opportunities and challenges [J].
Benjamin, EJ ;
Smith, SC ;
Cooper, RS ;
Hill, MN ;
Luepker, RV .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (04) :588-603
[15]   Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability [J].
Biasucci, LM ;
Liuzzo, G ;
Grillo, RL ;
Caligiuri, G ;
Rebuzzi, AG ;
Buffon, A ;
Summaria, F ;
Ginnetti, F ;
Fadda, G ;
Maseri, A .
CIRCULATION, 1999, 99 (07) :855-860
[16]   Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients [J].
Boersma, E ;
Pieper, KS ;
Steyerberg, EW ;
Wilcox, RG ;
Chang, WC ;
Lee, KL ;
Akkerhuis, KM ;
Harrington, RA ;
Deckers, JW ;
Armstrong, PW ;
Lincoff, AM ;
Califf, RM ;
Topol, EJ ;
Simoons, ML .
CIRCULATION, 2000, 101 (22) :2557-2567
[17]   Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women [J].
Bostom, AG ;
Silbershatz, H ;
Rosenberg, IH ;
Selhub, J ;
D'Agostino, RB ;
Wolf, PA ;
Jacques, PF ;
Wilson, PWF .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) :1077-1080
[18]  
BOTHIG S, 1989, INT J EPIDEMIOL S1, V18, P29
[19]   Projection of diabetes burden through 2050 - Impact of changing demography and disease prevalence in the US [J].
Boyle, JP ;
Honeycutt, AA ;
Narayan, KMV ;
Hoerger, TJ ;
Geiss, LS ;
Chen, H ;
Thompson, TJ .
DIABETES CARE, 2001, 24 (11) :1936-1940
[20]   Influence of C3 deficiency on atherosclerosis [J].
Buono, C ;
Come, CE ;
Witztum, JL ;
Maguire, GF ;
Connelly, PW ;
Carroll, M ;
Lichtman, AH .
CIRCULATION, 2002, 105 (25) :3025-3031